×
戻る Agenda
Extraction of Essential Issues and Strategic Proposals for Domestic Implementation of Decentralized Clinical Trial
Speaker(s)
Maria Resnick
Lead, Strategic Feasibility & Innovation,, Boehringer-Ingelheim Japan, Japan
Steve Geffon
Chief Commercial Officer, Greenphire, United States
Yoshihito Kondo, MPHARM
Executive Vice President, Clinical Operation, CMIC HOLDINGS Co., Ltd., Japan
Shuji Ozawa
Director, Future Design, CMIC HOLDINGS., Ltd., Japan
Ikiru Matsumoto, MPHARM, MSC
Business Development, iXgene, Japan